Can community hospitals in zambia master severe disease care?
NCT ID NCT07753681
First seen Aug 07, 2026 · Last updated Aug 07, 2026
Summary
This trial tests a new model of care called PEN-Plus, which brings specialized treatment for severe chronic diseases like diabetes, heart conditions, and sickle cell disease to first-level hospitals in Zambia. The goal is to train local health workers and set up clinics to manage these complex conditions closer to home. The study will see if this approach increases the number of patients diagnosed and treated effectively.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Supportive treatment including insulin, hydroxyurea, and clinic/training center setup
- What this could lead to
- If successful, this could expand access to life-saving care for severe chronic diseases in low-resource settings, potentially improving outcomes for thousands.
- What could go wrong
- The trial is early and focuses on implementation, so benefits may vary. Challenges like drug supply and training could limit impact.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Matero First Level Hospital
RECRUITINGLusaka, Lusaka Province, 10101, Zambia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Heart surgery in childhood: a hidden impact on speech and memory?
- Could sitting up make radiation therapy more comfortable?
- Digital nurse companion: could an app ease the burden of chronic illness?
- Could continuing a common heart drug before surgery save lives?
- A website designed to steer teens with heart defects away from vaping